U.S.C.

U.S.C.

This is the abbreviation for United States Code. Any reference to, for example, 26 U.S.C. §1273,means Title 26 of the United States Code and section 1273 of that Title.This format is considered the official citation.There are several publishers of the United States Code.An alternate citation might be seen as 26 U.S.C.S. §1273 (United States Code Service, published by Lawyers Cooperative Service and containing cross references to legal aids from the same publisher,including LexisNexis) or 26 U.S.C.A. §1273 (United States Code Annotated, published by West Publishing Company and containing cross references to legal aids from the same publisher, including Westlaw.) To find the complete text of United States Code Sections, visit the Web site of the U.S. Government Printing Office, www.gpoaccess.gov/uscode/index.html. See also section (federal code) for an alternate, but still official, Web site for research.

The Complete Real Estate Encyclopedia by Denise L. Evans, JD & O. William Evans, JD. Copyright © 2007 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
These provisions are similar to 28 U.S.C. [section] 1292(b), which sets forth the circumstances under which federal appellate courts may exercise jurisdiction over interlocutory appeals.
The purpose of this memorandum is to bring to your attention a recently enacted statutory provision that prescribes whether the Javits-Wagner-O'Day Act (41 U.S.C. 46 et seq., JWOD) or the Randolph-Sheppard Act (R-SA) (20 U.S.C.
102, Acquisition Workforce Training Fund, amends [SS] 37 of the Office of Federal Procurement Policy Act (41 U.S.C. [SS]433), requiring the General Services Administration (GSA) to establish an acquisition workforce training fund using a portion of the fees collected.
(3.) Federal Trade Commission Act, 15 U.S.C. s 45 (1914).
The letter reads in part, "FDA has determined that your 'CBD Lotion,' 'CBD Pain-Relief Patch,' 'CBD Tincture,' and 'CBD Disposable Vape Pen' products are unapproved new drugs sold in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), 21 U.S.C. 355(a) and 331(d).
Wilson Case No.: 17-76 Officials: WOOD, Chief Judge, and RIPPLE and HAMILTON, Circuit Judges Focus: Sufficiency of Evidence A grand jury indicted Jeffrey Wilson, in a twenty-one-count indictment, with the following offenses: (1) fraud in connection with the purchase or sale of securities, in violation of 15 U.S.C. 7j(b) and 7ff, and 17 C.F.R.
Chapter 15, 11 U.S.C. [section] 1508 requires the court to
As part of these new procedures, amendments were also made to 35 U.S.C. A* 271(e).
Thus, Sandoz refused to make the disclosures under 42 U.S.C. [sec] 262(l)(2)(A) and to participate in the "patent dance." Here, the Federal Circuit held that disclosure of the abbreviated biologic license application by the applicant to the reference product sponsor ("RPS") is optional despite the use of the word "shall" in 42 U.S.C.
Experience in prisoner litigation under 42 U.S.C. [section] 1983, in petitions under 28 U.S.C.
WHEREAS, pursuant to section 8(e) of the Federal Deposit Insurance Act, as amended ("FDI Act") (12 U.S.C. [section] 1818(e)), the Board of Governors of the Federal Reserve System ("Board") is of the opinion, for the reasons set forth in the accompanying Final Decision, that a final Order of Prohibition should issue against ADAM L.